|
EP0194972B1
(en)
*
|
1985-03-11 |
1992-07-29 |
Sandoz Ag |
Novel cyclosporins
|
|
US4814323A
(en)
*
|
1986-03-25 |
1989-03-21 |
Andrieu J M |
Process for the treatment and the prevention of AIDS and other disorders induced by the LAV/HTLV III virus
|
|
US4885276A
(en)
*
|
1987-06-03 |
1989-12-05 |
Merck & Co., Inc. |
Cyclosporin analogs with modified "C-9 amino acids"
|
|
US4798823A
(en)
*
|
1987-06-03 |
1989-01-17 |
Merck & Co., Inc. |
New cyclosporin analogs with modified "C-9 amino acids"
|
|
US4996193A
(en)
*
|
1989-03-03 |
1991-02-26 |
The Regents Of The University Of California |
Combined topical and systemic method of administration of cyclosporine
|
|
US5294604A
(en)
*
|
1989-12-20 |
1994-03-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating ocular diseases by periocular administration of cyclosporine A or G
|
|
ES2095926T5
(es)
*
|
1990-11-02 |
2001-02-16 |
Novartis Ag |
Cyclosporins.
|
|
DE69228130D1
(de)
*
|
1991-10-12 |
1999-02-18 |
Univ California |
Verwendung von thiolgruppen enthaltenden redox-proteinen zur reduktion von disulfidbindungen
|
|
HUP9900405A3
(en)
*
|
1995-07-17 |
2001-04-28 |
Scynexis Inc Durham |
Cyclosporin derivatives with anti-hiv effect
|
|
JP3089350B2
(ja)
*
|
1995-11-20 |
2000-09-18 |
ギルフォード ファーマシューティカルズ インコーポレイテッド |
シクロフィリンロタマーゼ活性の阻害剤
|
|
FR2757521B1
(fr)
|
1996-12-24 |
1999-01-29 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2757520B1
(fr)
|
1996-12-24 |
1999-01-29 |
Rhone Poulenc Rorer Sa |
Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
|
|
FR2757522B1
(fr)
|
1996-12-24 |
1999-01-29 |
Rhone Poulenc Rorer Sa |
Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2762843B1
(fr)
*
|
1997-04-30 |
1999-12-10 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2772768B1
(fr)
|
1997-12-19 |
2000-01-14 |
Rhone Poulenc Rorer Sa |
Nouveau procede de preparation de derives de cyclosporine
|
|
DE69912952T2
(de)
*
|
1998-06-12 |
2004-09-02 |
C-Chem Ag |
Cyclosporine
|
|
FR2780061B1
(fr)
|
1998-06-22 |
2001-09-07 |
Rhone Poulenc Rorer Sa |
Nouveau procede de preparation de derives de cyclosporine
|
|
USRE40987E1
(en)
|
1998-07-01 |
2009-11-17 |
Debiopharm S.A. |
Cyclosporin with improved activity profile
|
|
US6254860B1
(en)
*
|
1999-04-13 |
2001-07-03 |
Allergan Sales, Inc. |
Ocular treatment using cyclosporin-A derivatives
|
|
US6521595B1
(en)
*
|
1999-11-19 |
2003-02-18 |
Lg Chemical, Ltd. |
Nonimmunosuppressive [γ-hydroxy-methylleucine4] cyclosporin A, hair growth stimulator and external composition for skin using the same
|
|
CA2363274A1
(en)
|
1999-12-27 |
2001-07-05 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs for hepatitis c
|
|
ES2341534T3
(es)
*
|
2000-07-21 |
2010-06-22 |
Schering Corporation |
Peptidos como inhibidores de la serina proteasa ns3 del virus de la hepatitis c.
|
|
IL162137A0
(en)
|
2001-11-27 |
2005-11-20 |
Anadys Pharmaceuticals Inc |
D-ribofuranosylthiazolo -3-Ä4,5-dÜpyridimine nucl eosides and uses thereof
|
|
KR20040039622A
(ko)
*
|
2002-11-04 |
2004-05-12 |
주식회사 엘지생활건강 |
모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
|
|
US6987090B2
(en)
*
|
2002-05-09 |
2006-01-17 |
Lg Household & Health Care Ltd. |
Use of 3-position cyclosporin derivatives for hair growth
|
|
CN1678326A
(zh)
*
|
2002-06-28 |
2005-10-05 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2'－c－甲基－3'－o－l－缬氨酸酯核糖呋喃基胞苷
|
|
WO2005000308A2
(en)
|
2003-05-15 |
2005-01-06 |
Rigel Pharmaceuticals, Inc. |
Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c
|
|
GB0320638D0
(en)
|
2003-09-03 |
2003-10-01 |
Novartis Ag |
Organic compounds
|
|
JP2008512351A
(ja)
|
2004-07-13 |
2008-04-24 |
ノバルティス アクチエンゲゼルシャフト |
アルツハイマー病を処置するためのサイクロスポリン
|
|
RU2394589C2
(ru)
|
2004-07-14 |
2010-07-20 |
Новартис Аг |
Применение комбинации циклоспорина и пэгилированного интерферона для лечения гепатита с (hcv)
|
|
US20060025267A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Mircea Gradu |
Differential with torque vectoring capabilities
|
|
SI1802650T1
(sl)
*
|
2004-10-01 |
2012-03-30 |
Scynexis Inc |
Eter in tioeter substituirani ciklosporinski derivati za zdravljenje in preventivo pred infekcijami s hepatitisom c
|
|
JP4892486B2
(ja)
|
2004-10-01 |
2012-03-07 |
デビオファーム ソシエテ アノニム |
Ｃ型肝炎感染の治療のための［ｄ−ｍｅａｌａ］３−［ｅｔｖａｌ］４−シクロスポリンの使用、及び当該［ｄ−ｍｅａｌａ］３−［ｅｔｖａｌ］４−シクロスポリンを含む医薬組成物
|
|
US7196161B2
(en)
*
|
2004-10-01 |
2007-03-27 |
Scynexis Inc. |
3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
|
|
AU2005322241B2
(en)
|
2004-12-23 |
2010-02-18 |
Novartis Ag |
Compounds for flaviviridae treatment
|
|
KR20070087624A
(ko)
|
2004-12-23 |
2007-08-28 |
노파르티스 아게 |
Ｈｃｖ 치료용 조성물
|
|
EP1931696B1
(en)
|
2005-09-30 |
2011-02-16 |
Scynexis, Inc. |
Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection
|
|
CA2623865A1
(en)
*
|
2005-09-30 |
2007-04-12 |
Scynexis, Inc. |
Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection
|
|
AU2007254148B2
(en)
*
|
2006-05-19 |
2013-02-07 |
Scynexis, Inc. |
Method for the treatment and prevention of ocular disorders
|
|
WO2008069917A2
(en)
|
2006-11-20 |
2008-06-12 |
Scynexis, Inc. |
Novel cyclic peptides
|
|
WO2008127613A1
(en)
|
2007-04-11 |
2008-10-23 |
Scynexis, Inc. |
New pharmaceutical compositions
|
|
WO2008143996A1
(en)
|
2007-05-18 |
2008-11-27 |
Scynexis, Inc. |
New chemical processes
|
|
CN102083852A
(zh)
|
2008-06-06 |
2011-06-01 |
西尼克斯公司 |
环孢菌素类似物及其在治疗hcv感染中的应用
|
|
US20090306033A1
(en)
*
|
2008-06-06 |
2009-12-10 |
Keqiang Li |
Novel cyclic peptides
|
|
JP5780969B2
(ja)
*
|
2008-12-31 |
2015-09-16 |
サイネクシス，インコーポレーテッド |
シクロスポリンａの誘導体
|
|
CA2750227A1
(en)
*
|
2009-01-07 |
2010-07-15 |
Scynexis, Inc. |
Cyclosporine derivative for use in the treatment of hcv and hiv infection
|
|
MX2011007194A
(es)
*
|
2009-01-07 |
2013-07-12 |
Scynexis Inc |
Combinacion de un derivado ciclosporina y nucleosidos para tratar virus de hepatitis c (vhc).
|
|
US20110144005A1
(en)
*
|
2009-12-09 |
2011-06-16 |
Scynexis, Inc. |
Novel cyclic peptides
|